SCHEMBL24628362

SCHEMBL24628362

CN(C)S(=O)(=O)c1ccc(S(=O)(=O)Cc2ccccc2N2CCN(c3ccc(Cl)cc3F)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.46
HTT P42858 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
TP53 P04637 3/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 5/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
THRB P10828 1/20 0.42
GPR55 Q9Y2T6 2/20 0.41
CNR1 P21554 1/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29772887 1.00 LMNA (0.46) LMNAHTTSMN1; SMN2TP53GAA
SCHEMBL29772926 0.89 ALDH1A1 (0.46) LMNAHTTSMN1; SMN2TP53GAA
SCHEMBL21244041 0.89 TSHR (0.50) LMNAHTTSMN1; SMN2TP53ALDH1A1
SCHEMBL23536124 0.87 TSHR (0.39) LMNAHTTSMN1; SMN2TP53GAA
SCHEMBL29931867 0.87 TSHR (0.39) LMNAHTTSMN1; SMN2TP53GAA
SCHEMBL24628363 0.85 LMNA (0.44) LMNAHTTSMN1; SMN2TP53GAA
SCHEMBL29772850 0.85 LMNA (0.44) LMNAHTTSMN1; SMN2TP53GAA
SCHEMBL23536152 0.80 LMNA (0.40) LMNAHTTSMN1; SMN2TP53GAA
SCHEMBL29931786 0.80 LMNA (0.40) LMNAHTTSMN1; SMN2TP53GAA
SCHEMBL21244042 0.80 ALDH1A1 (0.52) LMNAHTTSMN1; SMN2TP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022150461-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2022-07-14 WO disclosed